What is Crestar Labs?
Crestar Labs operates as an accredited high-complexity clinical reference laboratory, specializing in esoteric toxicology and genetic analysis. The company serves a diverse clientele, including physician offices, substance abuse clinics, mental health facilities, and rehabilitation programs. Crestar Labs is committed to enhancing patient care and optimizing cost savings for providers by delivering rigorous diagnostic tests, supported by validated standards and a talented team. Their focus on quality ensures that reports are issued promptly, typically within 48 hours of sample receipt, with expert consultation readily available for interpretation.
How much funding has Crestar Labs raised?
Crestar Labs has raised a total of $675K across 2 funding rounds:
Debt
$350K
Debt
$325K
Debt (2020): $350K with participation from PPP
Debt (2021): $325K led by PPP
What's next for Crestar Labs?
The substantial enterprise-level funding and recent strategic investment signal a period of significant growth and potential expansion for Crestar Labs. This capital infusion is likely to fuel advancements in their specialized toxicology and genetic analysis services, potentially enabling broader market reach and the development of new diagnostic capabilities. The company's emphasis on quality and provider support positions it for continued success in the competitive clinical laboratory landscape, aiming to further solidify its value proposition in improving patient outcomes and operational efficiencies for healthcare partners.
See full Crestar Labs company page
